Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the pharma giant to end copycat sales after the FDA ended a years-long ...

Eli Lilly (NYSE:LLY) lands an $870 million pact with Camurus (CAMX) to build long-acting obesity treatments, tapping FluidCrystalslow-release tech to stretch dosing from days to weeks. Lilly's ...

In other recent news, Eli Lilly announced its acquisition of Verve Therapeutics for approximately $1.0 billion upfront, with a potential total value of $1.3 billion if certain development ...

MS Dhoni, the celebrated former Indian cricket captain, has been inducted into the ICC Cricket Hall of Fame, a testament to his remarkable 16-year international career. He amassed 17,266 runs and ...

He's not Eli Manning. But Jaxson Dart doesn't have to be. That calm, collected presence? It's there. The Ole Miss connection? There. The commitment to learning-not just plays, bu ...

POQUOSON — The starting quarterback on Poquoson High’s football team, Eli Tyndall admits the one-point loss to Strasburg in the Class 2 state semifinals last December still stings.

If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs. Should you invest in this top healthcare company before June 22?

PINE BELT, Miss. (WDAM) - A Richton man was killed in a motorcycle accident Sunday in Starkville, according to television station WCBI. The station said 37-year-old Jeremy Spiers was killed in a ...

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy for beginners now. On June 11, Eli Lilly announced a partnership with Juvena Therapeutics to develop new muscle-boosting drugs.

Montréal-based Eli Health has secured $17 million CAD ($12 million USD) in Series A funding to support the launch of its flagship hormone-monitoring technology product. The equity round was led by a ...

Eli Lilly (LLY) is reportedly nearing a deal to acquire gene editing startup Verve Therapeutics (VERV) for up to $1.3 billion, the Financial Times reported.

FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, are seen in a fridge at a health clinic in Hyderabad, India, April 14, 2025.